This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate or active pharmaceutical ingredient (API) in the development of drugs targeting central nervous system (CNS) disorders. Its structure, featuring a cyclopropylamine group and difluorophenyl moiety, makes it a valuable scaffold for designing compounds with potential antidepressant or anxiolytic properties. Researchers explore its application in modulating neurotransmitter systems, particularly serotonin and dopamine, to treat conditions like depression, anxiety, and other mood-related disorders. Additionally, its stereochemistry ((1R,2S)) is often critical for achieving optimal binding affinity and selectivity toward biological targets, making it a focus in enantioselective synthesis and drug optimization studies.